Enterprise Digital Health and Real-World Evidence (RWE) Platform for the Rapidly Emerging Psychedelics Industry.
CASE STUDIES USING NAVIGESIA
Remote Virtual Consultations
Lengthy psychological pre-intake assessments auto-run by the client ahead of consultation, or therapeutic session. This radically reduced missed information and provided a highly-standardized methodology for data gathering across multiple brick & mortar sites and clinicians.
Baseline Psychometrics & Risk Scoring
Complex risk assessments using a combination of open-source, commercial, or customized inventories to derive reportable indices of interest.
TREATMENT-RESISTANT DEPRESSION ASSESSMENT
PERSONALITY FACTORS (eg. Big 5)
MOOD & ANXIETY MEASURES
Digital Companion Tool for Psychedelic/Nootropic Company
During early release of a nootropic consumer product, the platform was leveraged to collect qualitative experience data helping to refine iterations on flavor, dosing, and other formulation characteristics.
Medical Records Mining
Using NLP (Natural Language Processing) tools, critical high-value data concepts (symptoms, disease, medications, lab results) are abstracted from large scale, unstructured primary care & mental health records (eFaxes, PDFs, scanned images, etc). Data is made available in standardized terminologic formats (SNOMED, LOINC, RxNORM, etc)
Microdosing & Patient-Reported Outcomes (PRO)
Quantification of a large crowd of self-reported psilocybin "microdose" patients and enthusiasts help identify baseline (pre-microdosing) and ongoing measures related to mood, sleep, anxiety, creativity, energy.
Personalized Client Trip Preparation
Focused instructions on diet, habits and overall pre-trip session preparation - helped clients focus particular attention to diet, lifestyle habits, sleep, intentions/goals.
Infusion Clinic Prior-Authorization
Information gathered from providers, patients (during and/or between visits) are collected and prior authorization forms are auto-generated saving significant administrative and clinical staff time.